WORK Medical (WOK) Amendment: Trillium Trading reports 0 shares

Rhea-AI Filing Summary

WORK Medical Technology Group LTD filing an Amendment No. 1 to a Schedule 13G/A reporting that Trillium Trading, LLC beneficially owns 0 shares of Class A Ordinary Shares (CUSIP G9767H125), representing 0% of the class. The filing is signed by a compliance officer on 06/09/2026 and states the holder has no voting or dispositive power.

Insights

Compliance & Governance Analyst

Schedules an ownership update showing zero beneficial holdings.

The amendment records that Trillium Trading, LLC holds 0 shares of Class A Ordinary Shares (CUSIP G9767H125) and reports 0% ownership. The filing explicitly lists zero sole and shared voting and dispositive power.

Because this is an ownership disclosure for "5 percent or less," the document is routine; subsequent filings would show material ownership changes if they occur.

Corporate Securities Attorney

Administrative amendment confirming no beneficial ownership or control.

The form identifies the filer as a Delaware LLC with an address in New York and provides the issuer's principal office in Auckland, New Zealand. The signature block shows a compliance officer dated 06/09/2026.

This disclosure meets reporting formalities for small holders; any future acquisition exceeding reporting thresholds would require updated disclosures.

Key Figures

Beneficial ownership: 0 shares Percent of class: 0% Filing signature date: 06/09/2026 +2 more

5 metrics

Beneficial ownership 0 shares Class A Ordinary Shares (CUSIP G9767H125)

Percent of class 0% Class A Ordinary Shares

Filing signature date 06/09/2026 Signature by Compliance Officer Louis Capone

Filer address 417 Fifth Avenue, New York, NY 10016 Trillium Trading, LLC principal business office

Issuer principal office 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001 WORK Medical Technology Group LTD

Key Terms

Schedule 13G/A, Beneficially owned, CUSIP, Dispositive power

4 terms

Schedule 13G/A regulatory

"Amendment No. 1 to Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned regulatory

"Amount beneficially owned: 0; Percent of class: 0%"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

CUSIP financial

"CUSIP No.: G9767H125 listed for Class A Ordinary Shares"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

Dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 0"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

WORK Medical Technology Group LTD

(Name of Issuer)

Class A Ordinary Shares

(Title of Class of Securities)

G9767H125

(CUSIP Number)

06/05/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G9767H125

1

Names of Reporting Persons

Trillium Trading, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power
6	Shared Voting Power
7	Sole Dispositive Power
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12

Type of Reporting Person (See Instructions)

SCHEDULE 13G

Item 1.
(a)	Name of issuer: WORK Medical Technology Group LTD
(b)	Address of issuer's principal executive offices: 1/88 COOK ST, 1/88 COOK ST, AUCKLAND CITY, NEW ZEALAND, 1001.
Item 2.
(a)	Name of person filing: Trillium Trading, LLC
(b)	Address or principal business office or, if none, residence: 417 Fifth Avenue, New York, New York 10016
(c)	Citizenship: Limited liability company organized under the laws of the State of Delaware, United States of America
(d)	Title of class of securities: Class A Ordinary Shares
(e)	CUSIP No.: G9767H125
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Trillium Trading, LLC

Signature:	Louis Capone
Name/Title:	Compliance Officer
Date:	06/09/2026

FAQ

What does WORK Medical (WOK) Schedule 13G/A Amendment No.1 report?

It reports that Trillium Trading, LLC beneficially owns 0 shares of Class A Ordinary Shares, equaling 0% of the class, per the amendment signed 06/09/2026.

Who filed the 13G/A amendment for WOK and where is the filer located?

Trillium Trading, LLC filed the amendment. The address listed is 417 Fifth Avenue, New York, New York 10016, and it is organized in Delaware.

Does Trillium Trading hold voting or dispositive power for WOK shares?

No. The amendment states zero for sole and shared voting power and zero for sole and shared dispositive power, indicating no control over the Class A Ordinary Shares.

What CUSIP and class are covered in this filing?

The filing covers Class A Ordinary Shares with CUSIP G9767H125, as stated in Item 2(d) and on the cover of the amendment.

When was the Schedule 13G/A amendment signed?

The signature block shows the amendment was signed by a compliance officer, Louis Capone, dated 06/09/2026.